Original BioMedicals Co., Ltd.

NT$15.25As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6483Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (63.64%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.11
PE TTM —
TSR TTM 40.55%
Mkt cap NT$1.019B
ROIC (38.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$17
8.35%
(82.96%)
Hold 7|0|11|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.28
0.27
0.30
0.31
42.14%
23.75%
28.07%
20.53%
RevenueNT$M
44.68
45.57
46.71
48.72
2.80%
4.83%
7.28%
12.08%
Peers (US$30.77M)
Cap (US$)
PE
32.68M
—
Capital
TTM
5Y
10Y
Leveragex
4.845
(0.554)
(0.360)
EBIT/Intx
1.310
0.059
0.063
Own earn%
7.67
23.60
53.71
Sh yield%
34.55
43.25
43.13
Owners
Insiders/Inst%
5.23
62.65
Short interest%
4.23
SBC / revenue%
2.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
6–10
$1 testx
—
Incr. ROIC%
9